期刊文献+

硫化氢供体对动脉粥样硬化大鼠内皮素-1生成的影响 被引量:6

Suppressive effect of hydrogen sulfide donor on endothelin-1 production in aorta of atherosclerotic rats
原文传递
导出
摘要 目的 探讨硫化氢(H2S)供体NaHS对动脉粥样硬化(AS)大鼠血浆及主动脉内皮素-1(ET-1)的影响.方法 30只雄性SD大鼠随机分为AS组、AS+ NaHS组及对照组,每组10只.采用维生素D3腹腔注射及高脂饲料喂养的方法制备AS大鼠模型.AS+NaHS组大鼠腹腔注射NaHS56μmol/(kg·d),余两组以生理盐水代替.8周后麻醉后处死大鼠,分别分离并留取血浆、主动脉及冠状动脉组织,以油红O染色观察大鼠主动脉根部和冠状动脉AS斑块的变化;硫电极法测定血浆H2S含量;放射免疫分析法检测血浆和主动脉ET-1含量,免疫组织化学法对主动脉ET表达进行定位检测;比色法测定血浆一氧化氮合成酶(NOS)及其亚型内皮型NOS(eNOS)、诱导型NOS (iNOS)的活性.结果 AS组、AS+ NaHS组及对照组大鼠主动脉根部AS面积百分比分别为(11.6±3.3)%,(1.6±1.1)%,(0.0±0.1)%,组间比较差异有统计学意义(F=97.675,P<0.05).三组大鼠冠状动脉AS面积百分比分别为(21.4±5.7)%,(4.8±2.5)%,(0.0±0.0)%,组间比较差异有统计学意义(F=97.519,P<0.05).AS组大鼠血浆H2S含量低于AS+ NaHS组和对照组[(22.0±3.1)比(33.3±6.2)、(27.9±1.0)μmol/L,P均<0.05].AS组和AS+ NaHS组大鼠血浆ET-1含量均高于对照组[(89.6±14.2)和(93.1±15.5)比(70.0±10.7)ng/L,P均<0.05];AS组与AS+ NaHS组差异无统计学意义(P>0.05).AS组和AS+ NaHS组大鼠主动脉ET-1含量均高于对照组[(11.9±4.9)和(8.2±2.5)比(3.8±1.2) ng/g,P均<0.05];AS+ NaHS组低于AS组(P<0.05).免疫组织化学结果显示对照组与AS+ NaHS组大鼠主动脉内皮细胞胞浆ET-1表达较弱,而AS组则为强阳性表达;AS组、AS+ NaHS组、对照组大鼠血浆NOS总活性分别为(51.8±10.0),(27.6±6.5),(25.4±5.6)U/ml、eNOS活性分别为(4.5±2.7),(8.7±3.9),(15.3±6.2) U/ml、iNOS活性分别为(47.3±10.7),(19.0±5.2),(9.9±4.0)U/ml,三组间比较差异均有统计学意义(NOS总活性:F =37.231,P<0.05、eNOS活性:F=14.600,P<0.05及iNOS活性:F =72.131,P<0.05).结论 H2S供体NaHS抑制AS大鼠中AS斑块的形成,上述效应可能与其保护血管内皮细胞,减少ET-1生成有关. Objective To examine the effect of H2S donor,sodium hydrosulfide (NaHS),on ET-1 level in plasma and aorta in rats with atherosclerosis (AS).Method Thirty male rats,weighting 200-220 g,were randomly divided into AS,AS +NaHS and control groups,n =10 in each group.Rats were given a single dose of vitamin D3 (700 000 U/kg) in the first three days and fed with a high-cholesterol diet for 8 weeks to induce AS.Rats in AS + NaHS group were intraperitoneally injected with an H2S donor NaHS,at a dose of 56 μmol/(kg · d) for 8 weeks.At the end of the experiment for 8 weeks,all the rats were sacrificed.The plasma was collected and the aorta and coronary tissues were isolated.The atherosclerotic lesions in both aorta and coronary arteries were detected using oil red 0 method.H2S concentration in plasma was determined with sulfide-sensitive electrode method.ET-1 levels in plasma and aorta were calculated by radioimmunoassay kit and the localization of ET-1 in the aorta was detected by immunohistochemistry.Plasma nitric oxide synthase (NOS),endothelial NOS (eNOS),inducible NOS (iNOS) were detected with colorimetry.Result AS plaque area in root of aorta of rats in AS group,AS + NaHS group and control group were (11.6 ± 3.3) %,(1.6 ± 1.1) %,(0.0 ± 0.1) % respectively.The difference in AS plaque area in root of aorta among the three groups was statistically significant (F =97.675,P 〈 0.05).AS plaque area in coronary artery of rats in AS group,AS + NaHS group and control group were (21.4 ± 5.7) %,(4.8 ± 2.5) %,(0.0 ± 0.0) % respectively.The difference in AS plaque area in coronary artery among the three groups was statistically significant (F =97.519,P 〈 0.05).Plasma H2S level in rats of AS group ((22.0 ±3.1) μmol/L) was significantly lower than that of control group ((27.9 ± 1.0) μmol/L) and AS + NaHS group ((33.3 ± 6.2) μmol/L,all P 〈 0.05).Compared with control group ((70.0 ± 10.7) ng/L),plasma ET-1 in rats of AS group ((89.6 ± 14.2) ng/L) and AS + NaHS group ((93.1 ± 15.5) ng/L,P both 〈0.05) were increased.However,there was no significant difference in plasma ET-1 content in rats between AS + NaHS group and AS group (P 〉 0.05).Compared with control group ((3.8 ± 1.2) ng/g),ET-1 content in aorta in rats of AS group ((11.9 ±4.9) ng/g) and AS + NaHS group ((8.2 ±2.5) ng/g,both P 〈 0.05) were increased,and ET-1 content in aorta in rats of AS + NaHS group was decreased compared with AS group (P 〈 0.05).Immunochemistry results showed that ET expression in cytoplasm in aortic endothelial cells in rats of AS group was strengthened,while ET expression in rats of control group and AS + NaHS group was weak.NOS activity of rats in control group,AS group and AS + NaHS group was (25.4±5.6),(51.8±10.0)and (27.6±6.5) U/ml,eNOS activity (15.3 ±6.2),(4.5 ±2.7) and (8.7± 3.9) U/ml,and iNOS activity (9.9 ± 4.0),(47.3 ± 10.7) and (19.0 ± 5.2) U/ml,respectively.Differences among the three groups were statistically significant (NOS activity:F =37.231,P 〈0.05,eNOS activity:F=14.600,P〈0.05,and iNOS activity:F=72.131,P〈0.05).Conclusion H2S donor NaHS reduced the AS plaque in AS rats.The mechanisms might involve the protective effect of H2S on the vascular endothelial cell,decreasing ET-1 production in aortal endothelium of atherosclerotic rats.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2015年第6期448-452,共5页 Chinese Journal of Pediatrics
基金 国家自然科学基金重点项目,北京市自然科学基金,教育部博士学科点专项科研基金
关键词 硫化氢 动脉粥样硬化 内皮素-1 ENDOTHELIN-1 Hydrogen sulfide Atherosclerosis
  • 相关文献

参考文献19

  • 1Tang C, Li X, Du J. Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system [ J ]. Curr Vasc Pharm acol, 2006, 4 (1) :17-22.
  • 2Liu YH, Lu M, Hu LF, et al. Hydrogen sulfide in the mammalian cardiovascular system [ J ]. Antioxid Redox Signal, 2012, 17(1) :141-185.
  • 3Streeter E, Ng HH, Hart JL. Hydrogen sulfide as a vasculoprotective factor [ J]. Med Gas Res, 2013, 3 ( 1 ) :9.
  • 4Yu XH, Cui LB, Wu K, et al. Hydrogen sulfide as a potent cardiovascular protective agent [ J ]. Clin Chim Acta, 2014, 437:78-87.
  • 5Wang Y, Zhao X, Jin H, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice [J]. Arterioscler Thromb Vasc Biol, 2009, 29(2) :173-179.
  • 6d' Uscio LV, Barton M, Shaw S, et al. Endothelin in atherosclemsis: importance of risk factors and therapeutic implications [ J ]. J Cardiovasc Pharmacol, 2000, 35 ( 4 Suppl 2) : $55-59.
  • 7Rodrtguez-Pascual F, Busnadiego O, Lagares D, et al. Role of endothelin in the cardiovascular system [ J ]. Phannacol Res, 2011,63(6) :463-472.
  • 8Kaoukis A, Deftereos S, Raisakis K, et al. The role of endothelin system in cardiovascular disease and the potential therapeutic perspectives of its inhibition [J]. Curt Top Med Chem, 2013, 13 (2) :95-114.
  • 9Huang ZY, Yang PY, Almofti MR, et al. Comparative analysis of the proteome of left ventricular heart of arteriosclerosis in rat [ J]. Life Sei, 2004, 75(26) :3103-3115.
  • 10Zhang H, Guo C, Zhang A, et al. Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice [ J]. Eur J Pharmacol, 2012, 697 ( 1-3 ) : 106-116.

二级参考文献13

  • 1石琳,杜军保,张春雨,闫辉,唐朝枢.气体信号一氧化氮与硫化氢在肺动脉舒张反应中的相互作用[J].中国药理学通报,2004,20(10):1112-1115. 被引量:26
  • 2陈晓波,杜军保,张春雨,唐朝枢,周伟仅.新型气体信号分子硫化氢对低氧大鼠肺动脉平滑肌细胞凋亡的影响[J].北京大学学报(医学版),2004,36(4):341-344. 被引量:33
  • 3冯丹,徐江,邹军.Omapatrilat对AngⅡ致人血管内皮细胞损伤的保护作用研究[J].中国药理学通报,2005,21(12):1498-1501. 被引量:6
  • 4Zhao W,Zhang J,Lu Y,Wang R.The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener[J].Embo J,2001,20(21):6008-16.
  • 5Ocampo C,Ingram P,Ilbawi M,et al.Revisiting the surgical creation of volume load by aorto-caval shunt in rats[J].Mol Cell Biochem,2003,251(1-2):139-43.
  • 6Du J,Hui Y,Cheung Y,et al.The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells[J].Heart Vessels,2004,19(2):75-80.
  • 7Zhao W,Wang R.H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms[J].Am J Physiol Heart Circ Physiol,2002,283(2):H474-80.
  • 8Wang Y,Wang D H.Prevention of endothelin-1-induced increases in blood pressure:role of endogenous CGRP[J].Am J Physiol Heart Circ Physiol,2004,287(4):H1868-74.
  • 9Piao F L,Cao C,Han J H,et al.Calcitonin gene-related peptide-induced suppression of atrial natriuretic peptide release through receptors for CGRP1 but not for calcitonin and amylin[J].Eur J Pharmacol,2004,483(2-3):295-300.
  • 10Black S M,Bekker J M,Johengen M J,et al.Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension[J].Pediatr Res,2000,47(1):97-106.

共引文献34

同被引文献63

引证文献6

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部